Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 5, Supplement 2, 1994   [Index by Author] 


Down List of Contributors
Down Subject Index
Down Introduction
Down Original Articles


[Search ALL Issues]

Front Matter (PDF) | Back Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

List of Contributors Back

List of contributors
Ann Oncol 1994 5: v; doi:10.1093/annonc/5.suppl_2.v [PDF] [Request Permissions]  

List of contributors
Ann Oncol 1994 5: S1; doi:10.1093/annonc/5.suppl_2.S1-a [PDF] [Request Permissions]  

Subject Index Back

Subject index Volume 5, supplement 2
Ann Oncol 1994 5: 165; doi:10.1093/annonc/5.suppl_2.165 [PDF] [Request Permissions]  

Subject index Volume 5, supplement 2
Ann Oncol 1994 5: S165; doi:10.1093/annonc/5.suppl_2.S165 [PDF] [Request Permissions]  

Introduction Back

R. Stupp, B. L. Samuels, and J. E. Ultmann
Management of lymphoma in the 1990s: Introduction to the Proceedings of the Fifth International Conference on Malignant Lymphoma
Ann Oncol 1994 5: S1-S3; doi:10.1093/annonc/5.suppl_2.S1 [PDF] [Request Permissions]  

R. Stupp, B. L. Samuels, and J. E. Ultmann
Management of lymphoma in the 1990s: Introduction to the Proceedings of the Fifth International Conference on Malignant Lymphoma
Ann Oncol 1994 5: S1-S3; doi:10.1093/annonc/5.suppl_2.S1-b [PDF] [Request Permissions]  

Original Articles Back

G. Bonadonna
Modern treatment of malignant lymphomas: A multidisciplinary approach?: The Kaplan Memorial Lecture
Ann Oncol 1994 5: S5-S16; doi:10.1093/annonc/5.suppl_2.S5 [Abstract] [PDF] [Request Permissions]  

S. A. Rosenberg
The treatment of Hodgkin's disease
Ann Oncol 1994 5: S17-S21; doi:10.1093/annonc/5.suppl_2.S17 [PDF] [Request Permissions]  

S. J. Horning
Low-grade lymphoma 1993: State of the art
Ann Oncol 1994 5: S23-S27; doi:10.1093/annonc/5.suppl_2.S23 [PDF] [Request Permissions]  

A. M. Levine
Lymphoma complicating immunodeficiency disorders
Ann Oncol 1994 5: S29-S35; doi:10.1093/annonc/5.suppl_2.S29 [Abstract] [PDF] [Request Permissions]  

D. Errante, V. Zagonel, E. Vaccher, D. Serraino, D. Bernardi, R. Sorio, M. Trovò, A. Carbone, S. Monfardini, and U. Tirelli
Hodgkin's disease in patients with HIV infection and in the general population: Comparison of clinicopathological features and survival
Ann Oncol 1994 5: S37-S40; doi:10.1093/annonc/5.suppl_2.S37 [Abstract] [PDF] [Request Permissions]  

F. B. Hagemeister, R. Khetan, P. Allen, P. McLaughlin, M. A. Rodriguez, F. Swan, Jr, J. E. Romaguera, and F. Cabanillas
Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas
Ann Oncol 1994 5: S41-S46; doi:10.1093/annonc/5.suppl_2.S41 [Abstract] [PDF] [Request Permissions]  

L. Grogan, N. Corbally, P. A. Dervan, A. Byrne, and D. N. Carney
Comparable prognostic factors and survival in elderly patients with aggressive non-Hodgkin's lymphoma treated with standard-dose Adriamycin-based regimens
Ann Oncol 1994 5: S47-S51; doi:10.1093/annonc/5.suppl_2.S47 [Abstract] [PDF] [Request Permissions]  

E. Brusamolino, E. Orlandi, E. Morra, G. Castelli, G. Pagnucco, A. Livraghi, C. Astori, A. Santagostino, M. Lazzarino, and C. Bernasconi
Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy
Ann Oncol 1994 5: S53-S57; doi:10.1093/annonc/5.suppl_2.S53 [Abstract] [PDF] [Request Permissions]  

F. B. Hagemeister, R. Purugganan, D. A. Podoloff, M. Hess, M. A. Rodriguez, P. McLaughlin, F. Swan, Jr., J. E. Romaguera, and F. Cabanillas
The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy
Ann Oncol 1994 5: S59-S63; doi:10.1093/annonc/5.suppl_2.S59 [Abstract] [PDF] [Request Permissions]  

B. Vaughan Hudson, G. Vaughan Hudson, D. C. Linch, and L. Anderson
Late mortality in young BNLI patients cured of Hodgkin's disease
Ann Oncol 1994 5: S65-S66; doi:10.1093/annonc/5.suppl_2.S65 [Abstract] [PDF] [Request Permissions]  

E. Kimby, M. Björkholm, G. Gahrton, B. Glimelius, H. Hagberg, B. Johansson, H. Johansson, G. Juliusson, M. Järnmark, E. Löfvenberg, A. Killander, R. Lerner, C. Lindemalm, U. Pettersson, K.-H. Robért, B. Simonsson, A.-M. Stalfelt, C. Sundström, E. Svedmyr, A.-M. Udén, B. Wadman, A. Wahlin, Å. Öst, and H. Mellstedt
Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: A randomized trial from the Lymphoma Group of Central Sweden
Ann Oncol 1994 5: S67-S71; doi:10.1093/annonc/5.suppl_2.S67 [Abstract] [PDF] [Request Permissions]  

P. McLaughlin, F. B. Hagmeister, F. Swan, F. Cabanillas, J. Romaguera, M.A. Rodriguez, M. S. Lee, O. Pate, A. Sarris, and A. Younes
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: High remission rates and reversion to negative of peripheral blood bcl-2 rearrangement
Ann Oncol 1994 5: S73-S77; doi:10.1093/annonc/5.suppl_2.S73 [Abstract] [PDF] [Request Permissions]  

M. J. Keating, P. McLaughlin, W. Plunkett, L. E. Robertson, S. O'Brien, V. Gandhi, V. Gregoire, L. Yang, and F. Cabanillas
Original article: Fludarabine – present status and future developments in chronic lymphocytic leukemia and lymphoma
Ann Oncol 1994 5: S79-S83; doi:10.1093/annonc/5.suppl_2.S79 [Abstract] [PDF] [Request Permissions]  

R. Somers, P. Carde, J. Thomas, U. Tirelli, J. J. Keunig, D. Bron, A. Delmer, R. De bock, C. De Wolf-Peeters, M. van Glabbeke, and N. Duez
EORTC study of non-Hodgkin's lymphoma: Phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma
Ann Oncol 1994 5: S85-S89; doi:10.1093/annonc/5.suppl_2.S85 [Abstract] [PDF] [Request Permissions]  

R. I. Fisher, E. R. Gaynor, S. Dahlberg, M. M. Oken, T. M. Grogan, E. M. Mize, J. H. Glick, C. A. Coltman, Jr., and T. P. Miller
A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: Results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study
Ann Oncol 1994 5: S91-S95; doi:10.1093/annonc/5.suppl_2.S91 [Abstract] [PDF] [Request Permissions]  

A. Preti, F. B. Hagemeister, P. McLaughlin, F. Swan, A. Rodriguez, P. Besa, J. D. Cox, P. K. Allen, and F. Cabanillas
Hodgkin's disease with a mediastinal mass greater than 10 cm: Results of four different treatment approaches
Ann Oncol 1994 5: S97-S100; doi:10.1093/annonc/5.suppl_2.S97 [Abstract] [PDF] [Request Permissions]  

E. Brusamolino, M. Lazzarino, E. Orlandi, A. Canevari, E. Morra, G. Castelli, E. P. Alessandrino, G. Pagnucco, C. Astori, A. Livraghi, F. Corbella, P. Franchini, and C. Bernasconi
Early-stage Hodgkin's disease: Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy
Ann Oncol 1994 5: S101-S106; doi:10.1093/annonc/5.suppl_2.S101 [Abstract] [PDF] [Request Permissions]  

E. M. Noordijk, P. Carde, A.-M. Mandard, W.A.M. Mellink, M. Monconduit, H. Eghbali, U. Tirelli, J. Thomas, R. Somers, N. Dupouy, and M. Henry-Amar
Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease
Ann Oncol 1994 5: S107-S112; doi:10.1093/annonc/5.suppl_2.S107 [Abstract] [PDF] [Request Permissions]  

G. Schellong, J. H. Brämswig, I. Hörnig-Franz, E. W. Schwarze, R. Pötter, and M. Wannenmacher
Hodgkin's disease in children: Combined modality treatment for stages IA, IB, and IIA: Results in 356 patients of the German/Austrian Pediatric Study Group
Ann Oncol 1994 5: S113-S115; doi:10.1093/annonc/5.suppl_2.S113 [Abstract] [PDF] [Request Permissions]  

B. W. Hancock, G. Vaughan Hudson, B. Vaughan Hudson, D. C. Linch, L. Anderson, and K. A. MacLennan
Hybrid LOPP/EVA is not better than LOPP alternating with EVAP: A prematurely terminated British National Lymphoma Investigation randomized trial
Ann Oncol 1994 5: S117-S120; doi:10.1093/annonc/5.suppl_2.S117 [Abstract] [PDF] [Request Permissions]  

G. P. Canellos
Critical review of the role of hemopoietic growth factors in dose intensification and outcome in the treatment of non-Hodgkin's lymphoma
Ann Oncol 1994 5: S121-S122; doi:10.1093/annonc/5.suppl_2.S121 [PDF] [Request Permissions]  

M. Engelhard, H. Gerhartz, G. Brittinger, A. Engert, R. Fuchs, B. Geiseler, D. Gerhartz, A. R. Haunauske, H.-J. Hartlapp, D. Huhn, W.-D. Ludwig, P. Meusers, P. Müller, H.-W. Pees, Ch. Peschel, H. Radtke, C. Schadeck-Gressel, G. Schlimok, W. Siegert, W. Spann, E. Terhardt, E. Thiel, W. Wilmanns, R. Brandmaier, H. J. Ehrlich, L. Färber, M. Parwaresch, M. Tiemann, and K. Lennert
Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: Results of a randomized double-blind placebo-controlled study with intensified COP-BLAM ± rhGM-CSF
Ann Oncol 1994 5: S123-S125; doi:10.1093/annonc/5.suppl_2.S123 [Abstract] [PDF] [Request Permissions]  

V. Zagonel, R. Babare, M. C. Merola, R. Talamini, R. Lazzarini, U. Tirelli, A. Carbone, and S. Monfardini
Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy
Ann Oncol 1994 5: S127-S132; doi:10.1093/annonc/5.suppl_2.S127 [Abstract] [PDF] [Request Permissions]  

R. Pettengell and D. Crowther
Haemopoietic growth factors and dose intensity in high-grade and intermediate-grade lymphoma
Ann Oncol 1994 5: S133-S141; doi:10.1093/annonc/5.suppl_2.S134 [Abstract] [PDF] [Request Permissions]  

A. Z. S. Rohatiner, A. Freedman, L. Nadler, J. Lim, and T. A. Lister
Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma
Ann Oncol 1994 5: S143-S146; doi:10.1093/annonc/5.suppl_2.S143 [Abstract] [PDF] [Request Permissions]  

H. C. Schouten, Ph. Colombat, L. F. Verdonck, N. C. Gorin, B. Björkstrand, G. Taghipour, and A. H. Goldstone
Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: The European Bone Marrow Transplant Group experience
Ann Oncol 1994 5: S147-S149; doi:10.1093/annonc/5.suppl_2.S147 [Abstract] [PDF] [Request Permissions]  

G. Liberti, R. Pearce, G. Taghipour, I. Majolino, and A. H. Goldstone
Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: A case-controlled analysis of the EBMT Registry data
Ann Oncol 1994 5: S151-S153; doi:10.1093/annonc/5.suppl_2.S151 [Abstract] [PDF] [Request Permissions]  

J. W. Sweetenham, S. J. Proctor, D. Blaise, A. Laurenzi, R. Pearce, G. Taghipour, and A. H. Goldstone
High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma: The EBMT experience
Ann Oncol 1994 5: S155-S159; doi:10.1093/annonc/5.suppl_2.S155 [Abstract] [PDF] [Request Permissions]  

J. O. Armitage
Early bone marrow transplantation in Hodgkin's disease
Ann Oncol 1994 5: S161-S163; doi:10.1093/annonc/5.suppl_2.S161 [Abstract] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.